ESO Education.

Transcription

1 ESO Education

2 Departments e-eso Masterclasses CancerWorld and Media Sharing Progress in Cancer Care World Oncology Forum Programmes Milan Via Turati, Milano - Italy Phone: Fax: eso@eso.net Bellinzona Piazza Indipendenza, Bellinzona - Switzerland Phone: Fax: eso@eso.net Breast Cancer breast@eso.net Eastern Europe and Balkan Region balkans@eso.net Eurasia eurasia@eso.net Euro-Arab School of Oncology easo@eso.net Euro-Latin American School of Oncology elaso@eso.net Lung Cancer lung@eso.net Lymphoma lymphoma@eso.net Prostate Cancer prostate@eso.net 2 n ESO Education

3 Welcome to the 2014 educational programme! 2014 will be mostly characterized by the new and better defined activity plan of the School: In Western Europe, clinical Masterclasses, courses and conferences, media activities and support to advocacy groups In Eastern Europe and Balkans, a dedicated Masterclass and more visiting professorships In Turkey, Russia and the Eurasia region, specific programmes tailored to the local needs In the Arab countries, mostly Egypt and Northern Africa, a Euro-Arab Clinical Masterclass In Israel, the second edition of our Conference on Breast Cancer in Young Women On the global level, a comprehensive e-learning programme For everybody, independently on the geographic area, we will make available the continuation of the Master Online Advanced Oncology in collaboration with the University of Ulm, Germany the Certificates of Competence in lymphoma and in breast cancer, the network of our Clinical Training Centres where junior and senior oncologists can spend from 3 to 6 months in the department of their interest. In the meantime, and as always, further collaboration with ECCO, EONS, ESMO, ESOP, ESSO, ESTRO, OECI and UICC will be continued. Looking forward to meeting you at one of the ESO events, in person or online. Alberto Costa, MD Scientific Director Fedro Peccatori, MD Assistant Scientific Director ESO Education n 3

4 Zoom to 2014 E-ESO ONLINE EDUCATIONAL RESOURCES e-grandround (weekly - live on the internet) see page 6 e-oncoreviews (monthly - live on the internet) see page 6 Soft Tissue Sarcoma Medical Education Programme see page 8 MASTERCLASSES 8-13 March th ESO-ESMO Masterclass in Clinical Oncology Ermatingen, Switzerland 8-13 March th ESO-EONS Masterclass in Oncology Nursing Ermatingen, Switzerland May th ESO-SIOP Europe Masterclass in Paediatric Oncology Ljubljana, Slovenia May 2014 Masterclass in Cancer Patient Advocacy: Working Towards Stronger and more Effective Advocacy in Europe Baveno, Italy 7-11 June 2014 Masterclass on Systematic Reviews in Cancer Care, Guidelines and Research Belfast, United Kingdom 4-7 October st ESO-ESSO Masterclass in Breast Cancer Surgery Ermatingen, Switzerland 8-12 November rd ESO-ESTRO Masterclass in Radiation Oncology Cascais, Portugal ADVANCED COURSES, SEMINARS AND SYMPOSIA 9-10 May th Clinical Oncology Update - Onkologia 2014 Kraków, Poland July th ESO-ESMO Course on Oncology for Medical Students Ioannina, Greece 3-4 October 2014 Update in the Management of Melanoma Bucharest, Romania INSIDE TRACK CONFERENCES February 2014 Active Surveillance for Low Risk Prostate Cancer Amsterdam, The Netherlands March 2014 ESO-m-icab Conference - Patient Participation in Melanoma Clinical Research Brussels, Belgium 4 n ESO Education

5 3-4 May 2014 (Part II) Breast Cancer Update Course (BCU) Milan, Italy 5-6 June th Familial Cancer Conference Madrid, Spain 6-7 November 2014 BCY2-2nd Breast Cancer in Young Women Conference Tel Aviv, Israel November 2014 Molecular Diagnostics, Genomics and Epigenetics in Clinical Oncology Rome, Italy EASTERN EUROPE AND BALKAN REGION PROGRAMME (EEBR) 28 June - 2 July th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology Brdo, Slovenia EURASIA PROGRAMME May st EURASIA Masterclass in Clinical Oncology Moscow, Russian Federation 20 September 2014 ESO-TURKECAG Endocrine Gland Cancers Symposium: Essentials of Thyroid Cancer Management Izmir, Turkey EURO-ARAB SCHOOL OF ONCOLOGY (EASO) March th EASO Workshop on Breast Reconstructive Surgery Cairo, Egypt June th EASO Masterclass in Clinical Oncology Casablanca, Morocco WORLD ONCOLOGY FORUM October 2014 Stop Cancer Now!: Treat the Treatable see page 23 Lugano, Switzerland CAREER DEVELOPMENT Certificate of Competence in Lymphoma see page 30 Certificate of Competence in Breast see page 31 Clinical Training Centres see page 32 Master Online Advanced Oncology see page 33 SDA Bocconi - Programme for Oncology Leaders in Europe (POLE) - 3rd Edition see page 36 ESO Education n 5

6 Distance Learning The European School of Oncology in co-operation with Nature Reviews in Clinical Oncology and Critical Reviews in Oncology Hematology is holding a series of distance learning programmes on the Internet, called e-sessions : e-grandrounds and e-oncoreviews. e-grandrounds : are weekly sessions on hot-topics held every Thursday from to CET without commercial sponsorship and are CME and ESMO-MORA accredited. e-oncoreviews : are monthly sessions held on the 1st Tuesday of every month from to CET designed to offer a balance and comprehensive overview on a specific topic, be it a tumour type, a type of therapy, diagnostic or therapeutic approach. The live e-sessions allow the highest level of interaction between the participant, the expert and the discussant, whilst further participants can join the recorded session which remains available for 6 months. e-sessions Dedicated Team of Discussants Department coordinator: D. Berthold, University Hospital of Canton Vaud, Lausanne, CH Lise Bentzen, Aarhus University Hospital, Aarhus, Denmark Fatima Cardoso, Champalimaud Cancer Center, Lisbon, Portugal Gilberto de Castro, Sao Paulo Cancer Institute, Sao Paulo, Brazil Véronique Diéras, Institut Curie, Paris, France Rachel Dommett, University of Bristol, Bristol, UK Daniel Helbling, Gastrointestinal Tumorcenter Zurich, Zurich, Switzerland Margaret Hutka, Royal Marsden Hospital, Sutton, UK Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina Fedro A. Peccatori, European Institute of Oncology, Milano, Italy Marco Siano, Cantonal Hospital, St. Gallen, Switzerland Wojciech M. Wysocki, Maria Sklodowska-Curie Memorial Institute Of Oncology, Kraków, Poland For further information: Francesca Marangoni, e-eso Managing Coordinator - e-eso@eso.net pub_breast_210x270_ _screen 12/09/12 11:54 Pagina 1 European School of Oncology Your Education live, free and just a click away! e-eso sessions weekly e-grandrounds and monthly e-oncoreviews Connect every Thursday of each week 1st Tuesday of each month 18:15 CET Learn with our experts and discussants Interact make your questions and receive live answers Access at any time, to any past recorded session (available for 6 months) Get CME and ESMO-MORA credits Play mastermind participant quiz JOIN LIVE AND INTERACT 9:15 SAN FRANCISCO 12:15 BOSTON, NEW YORK 17:15 LONDON, DUBLIN, LISBON 18:15 BRUSSELS, PARIS, MADRID, MILAN, JOHANNESBURG 19:15 ATHENS, TEL AVIV, CAIRO 20:15 MOSCOW 21:45 MUMBAI Your weekly/monthly appointment with education organised without commercial sponsorship by the European School of Oncology in collaboration with 6 n ESO Education

7 European School of Oncology Your Education live, free and just a click away! e-eso sessions weekly e-grandrounds and monthly e-oncoreviews Connect every Thursday of each week 1st Tuesday of each month 18:15 CET Learn with our experts and discussants Interact make your questions and receive live answers Access at any time, to any past recorded session (available for 6 months) Get CME and ESMO-MORA credits Play mastermind participant quiz JOIN LIVE AND INTERACT 9:15 SAN FRANCISCO 12:15 BOSTON, NEW YORK 17:15 LONDON, DUBLIN, LISBON 18:15 BRUSSELS, PARIS, MADRID, MILAN, JOHANNESBURG 19:15 ATHENS, TEL AVIV, CAIRO 20:15 MOSCOW 21:45 MUMBAI Your weekly/monthly appointment with education organised without commercial sponsorship by the European School of Oncology in collaboration with

8 E-ESO ONLINE EDUCATIONAL RESOURCE Your Education free and just a click away! MEDICAL EDUCATION PROGRAMME ON SOFT TISSUE SARCOMA Chair: Jean-Yves Blay, FR This educational programme on soft-tissue sarcoma is offered free-of-charge as an online resource with quiz interactivity, animation and narration to provide a dynamic experience. Completion of the programme offers 3 CME credits. 8 n ESO Education FURTHER INFORMATION Alexandra Zampetti, azampetti@eso.net, Tel:

9 active surveillance FOR LOW RISK PROSTATE CANCER February Amsterdam, The Netherlands Chairs: C.H. Bangma, NL - J. Hugosson, SE; Co-Chair: L. Klotz, CAN Honorary Chair: L.J. Denis, BE ESO Prostate Cancer Programme Coordinator: R: Valdagni, IT Scientific Coordinators: M.J. Roobol, NL - S. Carlsson, SE/US Over the years there has been increasing acceptance of active surveillance for prostate cancer as an alternative to radical treatment for men with low risk prostate cancer. Unless the overdiagnosis of indolent prostate cancer is reduced by alternative diagnostic strategies, active surveillance will continue to play an important role. The challenge is to determine how new imaging methods and biomarkers can improve patient selection and how to incorporate drugs into active surveillance programs. ESO 2nd Inside Track Conference Active Surveillance for Low Risk Prostate Cancer is aimed to be an interactive educational activity in which attendees will enjoy presentations by internationally renowned researchers on active surveillance, who have helped develop and evaluate technologies that may change the selection and monitoring of patients, and take part in workshops on multiple topics, from the different experiences on active surveillance worldwide to quality of life of patients who have accepted the observational strategy. Learning objectives: Update on active surveillance Participate in a multidisciplinary discussion on pros and cons of active surveillance Discuss intriguing issues such as patient selection, the need for new diagnostic tools and how to change ongoing protocols Share the experiences on active surveillance programmes worldwide Main topics: Participant s profile: Urologists Radiation oncologists Medical oncologists Biostatisticians Pathologists Investigators in outcomes research and genomics THE REGISTRATION DEADLINE IS PASSED Overdetection and overtreatment The worldwide experience Selection and monitoring for active surveillance Application of emerging technologies and biomarkers for screening, surveillance and treatment Quality of life of men on active surveillance Active surveillance versus focal therapy In collaboration with Endorsed by Rita De Martini, prostate@eso.net, ph ESO Education n 9

10 13 TH ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY 8-13 March Ermatingen (Lake Constance), Switzerland Chairs: N. Pavlidis, GR - R.A. Stahel, CH Scientific Co-ordinators: W. Gatzemeier, IT - R. Popescu, CH Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. The Clinical Sessions will be complemented by Tumour Board discussions. Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and the faculty. All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the side effects, oral therapy and palliative care sessions will be attended jointly. Learning objectives: Improve medical oncologists skills Help in preparing for the national board exam Practising case discussion Deep focus on breast, gastro-intestinal, genitourinary, gynaecological, head and neck and lung cancers Compact update on haematological diseases, supportive care, skin toxicity, the role of PET in oncology, cancer of unknown primary, biology of cancer, bone health and cancer, fertility preservation, sarcoma and GIST, health economics, new emergencies, brain tumours, bio-informatics and melanoma Main topics: Breast cancer Gastro-intestinal tumours Genito-urinary cancers Gynaecological cancers Head and neck cancer Lung cancer and mesothelioma Participant s profile: Age between 30 and 40 years At least 2-3 years experience in medical oncology or clinical oncology Involvement in scientific activities Fluency in English THE APPLICATION DEADLINE IS PASSED held in collaboration with the Flims Alumni Club The 2014 Masterclass is: part of the Master Online Advanced Oncology of the University of Ulm Francesca Marangoni, fmarangoni@eso.net, ph n ESO Education

11 7 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 8-13 March Ermatingen (Lake Constance), Switzerland Chairs: A. Margulies, CH - L. Sharp, SE Scientific Co-ordinator: B. Grube, DK Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans The Masterclass in Oncology Nursing programme is designed for European advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-to-date oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care. Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as assessment and decision making, communication skills, complex symptom management, research in nursing, psychosocial consequences of cancer therapy to mention a few. Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant s role in clinical leadership. Case studies will be presented by the participants and will explore nursing practice focusing on special aspects of care. In joint clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts. Special joint sessions will highlight and support the growing need for multidisciplinarity in chosen topics. Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up. Learning objectives: Understand new developments in oncology disease management Recognise and describe acute and late adverse effects of cancer and its treatment Identify complex patient needs across the diagnostic and oncology treatment trajectory Demonstrate advanced communication skills in managing oncology nursing care Critically appraise the evidence for cancer symptom management and intervention Reflect on theoretical underpinnings of decision making Describe the role of the advanced oncology nurse in leading clinical nursing care Participant s profile: Person working at an advanced nursing practice level, and with at least 3-5 years of clinical oncology nursing practice Person involved in direct patient care also combined with the management, organisation and co-ordination of cancer patient care Fluency in English (reading and speaking) Member of an EONS member society or individual member of EONS THE APPLICATION DEADLINE IS PASSED Main topics: Medical management, treatment options Effective symptom management and interventions Evidence based knowledge Newer areas of oncology nursing Improve patient experience and outcomes European Oncology Nursing Society, EONS Secretariat Att. Rudi Brike E. Mounierlaan Brussels, Belgium Ph Fax eons.secretariat@cancernurse.eu ESO Education n 11

12 ESO-M-ICAB CONFERENCE - PATIENT PARTICIPATION IN MELANOMA CLINICAL RESEARCH March Brussels, Belgium Chair: B. Ryll, SE Recent unprecedented progress in melanoma therapies can for the first time provide hope for patients in advanced stages of the disease. However, navigating a fast-evolving treatment landscape presents a real challenge, not only for patients but also for their advocates. With novel treatments in different stages of development, the most promising agents are often only accessible in a clinical trial setting. For this reason, access to and participation in clinical studies strongly shape the reality for stage 4 and increasingly, also stage 3 melanoma patients. The current logistical, ethical and humane challenges to melanoma patients enrolment in clinical trials now appeal for a change of paradigm in the design and conduct of these trials. This conference, organised jointly by m-icab and ESO, will therefore focus on patient participation in melanoma clinical research, with an update on the latest treatment developments (Session 1), how patients gain access to these (Session 2), the aspects of clinical trials that are problematic for melanoma patients (Session 3, 4) and a panel discussion involving all stakeholders on the melanoma clinical trial of the future and on concrete steps on how patients can get involved in this process (Session 5). In the past, m-icab has combined advisory board activites with functions of a European platform for melanoma patients. In order to stay true to our mission, to systematically address the problems faced by melanoma patients across Europe in a constructive, collaborative and result-orientated way, we need to make the step forward through a more structured organisational approach. The second day of the conference will therefore focus on the establishment of a European platform for melanoma patient advocacy (Session 6 and 7). In addition, we will offer workshops to support capacity building in the melanoma patient advocacy community. Learning objectives: Providing information about recent developments in clinical research to melanoma patients and their advocates to help them to efficiently access the best available treatments Voicing the concerns of melanoma patients with respect to the current model of drug development and initiate a constructive dialogue between the different stakeholders how these can be best addressed, the results of this discussion will be summarized in a statement paper Providing a platform for the formation of a European network of melanoma patient advocacy groups THE APPLICATION DEADLINE IS PASSED Acknowledgment: ESO and M-icab are grateful to the following companies for supporting this conference: Amgen, Bristol Myers Squibb, GlaxoSmithKline Oncology, Novartis Oncology and Roche. Participant s profile: The conference is intended for melanoma patients, their advocates and any stakeholders with interest in patientcentered clinical research Fluency in English Corinne Hall, chall@eso.net, ph: n ESO Education

13 Breast Cancer Update course (BCU) Part II - 3/4 May Milan, Italy Chairs: M. Aapro, CH - F. Cardoso, PT - H.S. Rugo, US Within the 2013 educational offer, ESO has established a high-level course on breast cancer tailored for trained oncologists in all disciplines with the aim to provide an update on the state-of-the-art therapeutic options as well as an overview of the latest advances in the field. The programme is designed with plenary lectures as well as meet-the-professor group sessions offering balanced and blended educational contents. It furthermore presents sessions in leadership skills, which are highly relevant in consideration of the participants profile. BCU will be developed as a two-level course, the first organised in 2013 and the second to be organised in 2014, with the same participants who will commit to attend a 2-year programme. The second cohort will be developed with the first course in 2015 and the second part in Learning objectives: Update on the state-of-the-art therapeutic options Provide an overview of the latest advances in the field Strengthen leadership skills Improve presentation skills Debate controversies and challenges in breast cancer treatment Main topics: Advances in breast cancer: Key messages in 2013 Progress in supportive care From science to clinical practice Leadership skills Presentation skills Controversies and challenges in breast cancer treatment The voice of the patient Meet-the-expert, breakout sessions Participant s profile: Age between 30 and 45 years Working experience in the field of oncology of 5 or more years from specialization Involvement in scientific activities Fluency in English Commitment to attend the 2-year programme (November 2013 and May 2014) The application deadline for the second BCU co-hort will be announced in SHARING PROGRESS IN CANCER CARE Sharing Progress in Cancer Care programme (SPCC) is a pioneering partnership between the European School of Oncology and some of the world s leading pharmaceutical companies. This programme is organised through unrestricted grants provided by Novartis Oncology and Genomic Health, sustaining members of the SPCC programme. Francesca Marangoni, fmarangoni@eso.net, ph ESO Education n 13

14 6 th Clinical Oncology Update - Onkologia May Kraków, Poland Scientific Co-ordinator: W. Wysocki, PL The Conference offers plenary lectures delivered by the leading experts in the field, focusing on the state-of-the-art therapies and concluding with take-home messages. Lectures will cover the current standards of modern oncology, with special attention paid to practical aspects of effective cancer treatment. On 10 May the leading European experts, invited jointly by ESO and Medycyna Praktyczna Onkologia, will deliver lectures on practical clinical issues, such as management on patients with neuroendocrine tumors, therapy-induced mucositis, malignant bowel obstruction and nutrition, prostate cancer, kindey cancer, etc. Fertility issues in cancer patients will be discussed, too. There will also be session on electrochemotherapy. All lectures will be interactive. An electronic system will allow participants to answer the questions, solve the quizzes and join the speakers in clinical case discussions. The Conference will be entirely in English (or in other languages, but simultaneously translated into English). Learning objectives: Update on the most important advances in the field of gastrointestinal malignancies, breast cancer, prostate cancer etc. Improve the skills and knowledge on practical clinical issues, such as management of patients with side-effects of radiotherapy and chemotherapy, with special focus on targeted therapies, new strategies in advanced GI cancer patients and in breast cancer treatment Understand current options for palliation of malignant bowel obstruction and multiple skin malignant tumors Participant s profile: Medical oncologists as well as radiation and surgical oncologists Other medical specialties involved in cancer care (e.g. radiologists, pathologists etc.) Medical students Fluency in English DEADLINE EARLY REGISTRATION: 1 APRIL 2014 Main topics: Colorectal cancer Breast cancer Gastric cancer Urinary bladder cancer Palliation of malignant obstruction of airways and alimentary tract Side-effects of chemotherapy and radiotherapy 14 n ESO Education Michał Bando Medycyna Praktyczna - Conferences 41 Krakowska Str., Krakow, Poland Phone Fax Mobile michal.bando@mp.pl; onkologia2014@mp.pl

15 1 ST EURASIA MASTERCLASS IN CLINICAL ONCOLOGY May Moscow, Russian Federation Chairs: D. Zaridze, RU - A. Costa, IT The Masterclass offers plenary lectures focusing on the state-of-the-art clinical evaluation and treatments with reference to the clinical guidelines and concluding with take-home messages. Furthermore, practical training will be offered in the frame of clinical case presentations prepared and presented by the faculty and participants for an interecative discussion. Participation is compulsory throughout the event. The Masterclass will be entirely in English and fluency in English is compulsory for admission. Learning objectives: Full immersion Clinically-oriented Multidisciplinary An international faculty of experts delivering focusing on breast, colorectal and cervical cancers Main topics: Breast cancer Colorectal cancer Cervical cancer Participant s profile: Age up to 40 years At least 2-3 years experience in clinical oncology Involvement in scientific activities Fluency in English THE APPLICATION DEADLINE IS PASSED Daniela Mengato, dmengato@eso.net, ph ESO Education n 15

16 5 th ESO-SIOP Europe MASTERCLASS IN PAEDIATRIC ONCOLOGY May Ljubljana, Slovenia Chairs: R. Riccardi, IT - M.C.G. Stevens, GB - A. Eggert, DE Co-Chair: B. Morland, GB ESO and SIOP-Europe are pleased to announce the fifth Masterclass in Paediatric Oncology. This clinically-oriented educational programme has been designed for young paediatric oncologists who wish to improve their skills in clinical management of common childhood tumours. It is designed to offer a unique learning experience, providing practice-oriented training and the teaching sessions will focus on the application of the most recent research findings to clinical practice. Learning objectives: Qualified training in paediatric oncology to improve their knowledge of the main topics listed below Skills in dealing with cancer problems as a whole Improve knowledge of current clinical practice and state of the art treatment Participant s profile: Age between 30 and 40 years 2-4 years experience in paediatric oncology Involvement in scientific activities and clinical trials Fluency in English Main topics: Central nervous system tumours Neuroblastoma Soft-tissue sarcoma Bone tumours Wilms tumour Rare tumours THE APPLICATION DEADLINE IS PASSED Supported by Alexandra Zampetti, azampetti@eso.net, ph: n ESO Education

17 MASTERCLASS IN CANCER PATIENT ADVOCACY: WORKING TOWARDS STRONGER AND MORE EFFECTIVE ADVOCACY IN EUROPE May Baveno, Italy Steering Committee: K. Apostolidis (ECPC) - E. Briers (Europa Uomo) - J. Geissler (CML Advocates Network) - S. Knox (Europa Donna) - K. Oliver (International Brain Tumour Alliance - IBTA) - B. Ryll (M-ICAB) - M. Wartenberg (IKCC and SPAEN) - R. Wilson (SPAEN) Scientific Co-ordinator: K. Redmond (ESO) While many cancer patient organisations hold training initiatives for members, there are limited opportunities for highly experienced cancer patient advocacy leaders to enhance their understanding of key cancer policy issues and develop their advocacy skills. Therefore ESO, with encouragement from a number of advocacy leaders, has decided to organise a Masterclass on Cancer Patient Advocacy similar to the Masterclasses that the School runs on clinical oncology, paediatric oncology, cancer surgery, cancer nursing, oncology pharmacy and radiotherapy (in collaboration with societies such as ESMO, EONS, ESTRO, SIOPE, ESOP, ESSO etc.). Learning objectives: Update leaders of European cancer patient organisations about how to run a successful organisations Discuss how cancer patients can have a stronger impact in health policy and cancer research Review successful strategies that can be used by European cancer patient organisations to address common problems/issues Help participants to develop skills to support their roles as advocates Provide a forum for networking and exchange of best practice. Main topics: Managing advocacy organisations Using Evidence in cancer patient advocacy Securing a patient voice in cancer research Ensuring the long-term sustainability of a non-profit organisation Managing risk in NGOs Cancer observatory Participant s profile: Executive or board position in European cancer patient organisations or international cancer patient organisations that are active at a European level Nominated as representative of their organisation Fluency in English DEADLINE attendees will be nominated by organisations Acknowledgement: ESO is grateful to the following companies for supporting this event: Eli Lilly, GlaxoSmithKline Oncology, Helsinn, Novartis Oncology and Roche. The Masterclass will be held in collaboration with the following European cancer patient organisations: ECPC - the European Cancer Patient Coalition Europa Donna - the European Breast Cancer Coalition Europa Uomo - the European Prostate Cancer Coalition EuropaColon CML Advocates Network/Leukemia Patient Advocates Foundation IBTA - International Brain Tumour Alliance SPAEN - Sarcoma Patients EuroNet IKCC - International Kidney Cancer Coalition LuCE - Lung Cancer Europe Myeloma Patients Europe Rita De Martini, rdemartini@eso.net, ph ESO Education n 17

18 6 th Familial Cancer Conference 5-6 June Madrid, Spain Chairs: R. Eeles, GB - H. Vasen, NL - J. Benitez, ES The 6th Familial Cancer Conference hosted once again at the Spanish National Cancer Research Centre (CNIO) aims to present the advances in this field from a multidisciplinary point of view. As you know, familial cancer has become an important challenge for oncologists, geneticists, molecular biologists and other professionals, due to its implications not only at the individual but also at the familial and social level. This type of cancers affect several members of a single family, being the identification of high risk families, the knowledge of the genes responsible for specific diseases and their biological functions, the clinical follow up of mutation carriers, the development of new treatments and the discovery of tailored drugs, some of the different challenges involved. In most of countries, the number of professionals working in familial cancer has increased in the last years, demonstrating the interest that has woke up in our society. The Conference wants not only to cover and update numerous topics related to these genetic diseases but also to be a forum of discussion and meeting for professionals, either experienced clinicians and scientists or young people that are starting to work, or just interested in this exiting world. Learning objectives: Update recent advances in familial cancer To better define the genetic profile of these cancers and the clinical management of families and patients Lear in the new therapeutic strategies based in animal models Analyze the impact of the new technologies and their contribution to familial cancer risk Main topics: General concepts in familial cancer; genetic variants and familial cancer; genetic counseling Common cancers: The family of breast cancer genes; selection criteria and clinical management; new treatments based in animal models and massive sequencing; colorectal cancer and prostate cancer; genetic and clinical management Other hereditary syndromes: Familial pheocromocitoma; pancreatic cancer; PTEN-Hamartoma syndromes; familial renal carcinoma; familial melanoma; li Fraumeni syndrome; gastric carcinoid; Fanconi anemia New technologies applied to research and clinical diagnosis; the role of Consortia in massive sequencing; what to do with the incidental findings? 18 n ESO Education Participant s profile: Postgraduate medical doctors at any stage of clinical career Participants interested in familial cancer from a clinical or genetic point of view Experienced clinicians or genetists, and oncology/ biochemistry/biology trainees Scientists (PhD) DEADLINES Abstract submission: 15 May 2014 Final registration: 15 May 2014 In collaboration with Mercedes Moro Scientific Events Office - Centro Nacional de Investigaciones Oncológicas (CNIO) (Spanish National Cancer Research Centre) Melchor Fernandez Almagro Madrid, Spain meetings@cnio.es - Ph: Fax or contact: Daniela Mengato, dmengato@eso.net, ph

19 MASTERCLASS ON SYSTEMATIC REVIEWS IN CANCER CARE, GUIDELINES AND RESEARCH 7-11 June Belfast, United Kingdom Chairs: M. Clarke, GB - P. Johnston, GB Scientific Co-ordinator: G. Griffith, GB This 5-day course will take participants through the key steps in preparing a systematic review of research in cancer that they can use to guide decisions about treatment, guidelines or the design of new research. Each participant will bring a topic for a systematic review to the Masterclass, and this will form the basis of the problem-based learning approach that will be use throughout the course. Each day of the Masterclass will include one or two formal lectures from experts in the relevant topic area, as well as group discussions relating to that topic area, drawing on the knowledge of the expert. The group discussions will be a mixture of whole-group work, and smaller discussions in which participants will be divided into small parallel groups to tackle specific issues relating to their review questions. These small groups will be facilitated by experienced systematic reviewers from the Faculty, and will conclude with feedback from one member of each small group about the specific aspect of their review. Learning objectives: Formulation of the question Choice of inclusion and exclusion criteria, and selection of outcomes Development and implementation of a search strategy Application of the inclusion and exclusion criteria, and appraisal of quality and risk of bias in potentially eligible studies Data extraction Planning and conduct of meta-analyses, including subgroup and sensitivity analyses Exploration of heterogeneity Drawing conclusions and discussing implications for practice and research Main topics: Question formulation Eligibility criteria Outcome selection Search strategy Determining eligibility and data extraction Study quality and risk of bias Statistical analyses Heterogeneity Implications for practice and research Participant s profile: Healthcare practitioners with at least two years experience in the provision of care to cancer patients Familiarity with research into the effects of interventions for cancer patients, including randomized trials Basic understanding of the role of systematic reviews as a source of knowledge for decision making Fluency in English THE APPLICATION DEADLINE IS PASSED In collaboration with Francesca Marangoni, fmarangoni@eso.net, ph ESO Education n 19

20 ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology 28 June - 2 July Brdo, Slovenia Chairs: T. Cufer, SI - R. Herrmann, CH This residential programme has been designed for medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national or ESMO board exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from a basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology. The programme focuses on cancer pathology and molecular biology, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion. All participants will reside at the Masterclass venue and participation is mandatory throughout the course. The faculty is encouraged to stay at the venue for the entire duration of the class and interact with the students. At the end of each of the five days a learning self-assessment discussion with the chair of the course will be provided. Learning objectives: To update the knowledge on basic science of clinical and medical oncology To enhance the competence and practical performance in systemic therapy of malignancies To enhance the competence and practical performance in multidisciplinary cancer care To update knowledge and get additional skills in supportive as well as palliative care To prepare for the board exam in clinical/medical oncology DEADLINE By application only: 27 April 2014 Participant s profile: Age up to 40 years At least 2-3 years experience in medical oncology Fluency in English Main topics: Cancer biology/pathology Pharmacology Breast cancer Gastro-intestinal tumours Lung cancer and mesothelioma Head and neck cancer Genito-urinary cancers Sarcomas 20 n ESO Education Roberta Ventura, rventura@eso.net, ph

21 11 th ESO-ESMO COURSE ON ONCOLOGY FOR MEDICAL STUDENTS July Ioannina, Greece Chair: N. Pavlidis, GR Core faculty: A. Cervantes, ES - F. Geara, LB - G. Pentheroudakis, GR - I. Rubio, ES R. Stahel, CH - J.B. Vermorken, BE Although cancer is a major problem, undergraduate education on cancer medicine is still not uniform or well organized in many medical schools worldwide. It has been recognized that a complete and proper teaching portfolio should include learning on cancer control (epidemiology, prevention and screening), clinical skills, patients communications skills and palliative care. The principle philosophy of this course is to introduce medical students to the major aspects on clinical oncology. The first day of the course is mainly dedicated to basic principles of cancer treatment, whereas the rest of the days are dealing with the diagnosis and therapeutic management of the most common tumours. The teaching is interactive with clinical case presentations and an exam every day. Adequate educational material is provided to the students. Distinguished professors from various European and non European universities are invited to teach. The duration of the course is 5-full days. Learning objectives: Basics of cancer therapeutics Clinical overview, diagnosis and treatment of common tumours Supportive and palliative treatment Participant s profile: Sixth-year medical students Forty medical students selected by ESO Committee Main topics: Basics in surgical oncology Basics in radiation oncology Basics in systemic treatment (chemotherapy, hormonotherapy, immunotherapy) Supportive and palliative care Introduction to clinical trials Head and neck cancer Breast cancer Gynaecological cancers (ovarian, uterus, cervix) Gastrointestinal cancers (gastric, colorectal, pancreas, hepatobiliary) Lung cancer Lymphomas Urogenital cancers (prostate, testicular) Deadline BY APPLICATION ONLY: 14 APRIL 2014 We are grateful to the following organisations for their co-operation in the promotion of the course European Medical Students Association Association of Medical Schools in Europe In collaboration with University of Ioannina Dimitra Stamouli University of Ioannina, Medical School Div. of Medical Oncology GR Ioannina, Greece Ph Fax oncolsec@cc.uoi.gr ESO Education n 21

22 ESO-TURKECAG ENDOCRINE GLAND CANCERS SYMPOSIUM: ESSENTIALS OF THYROID CANCER MANAGEMENT 20 September Izmir, Turkey TURKECAG Chairs: A. Costa IT/CH - B.M. Gulluoglu, TR - R. Pandev, BG Scientific Co-ordinator: O. Makay, TR Türk Endokrin Cerrahi Araştırma Grubu 2009 The symposium will focus on topics about clinical decision making at every step of thyroid cancer surgical management. Educational, key-note and state-of-art lectures will follow interactive panel discussions with invited faculty. The lectures will cover main aspects of rational surgical approach for both primary and recurrent thyroid cancers, including their etiology, epidemiology and biology. This one-day symposium will meet the most known experts of the field to cover all practical issues on thyroid cancer surgery. The audience will have chance to establish interactive discussions with the invited faculty all throughout the event. This clinically oriented symposium is suitable for residents as well. Language of the meeting will be English. Learning objectives: Update the etiology and current trends in frequency of thyroid cancer in different parts of the world Understand the biology of thyroid cancer initiation and progression Acquire the evidence based clinical decision making process for patients with every stage of the disease Learn how to manage difficult thyroid cancer cases Understand the ways and implications of safe neck surgery for cancer Discuss the advantages of multidisciplinary approach to thyroid cancer cases Main topics: Current epidemiology of thyroid cancers Molecular biology of thyroid cancers Minimal thyroid cancer management Essentials of neck dissections for thyroid cancers Safe neck surgery Managing difficult cases (recurrent and locally advanced cancer) 22 n ESO Education Participant s profile: Age between 25 and 50 years Mainly endocrine surgeons, general surgeons and surgical oncologists, endocrinologists, nuclear medicine physicians, radiologists, pathologists, medical oncologists with a minimum experience of 3 years on thyroid cancer management Currently working at a comprehensive unit / institution in which thyroid cancer case load is high Residents may apply Fluency in English is required DEADLINE APPLICATION: 15 August 2014 Sertac Ata Guler, MD Executive Secretary to TURKECAG Address: Kusdili cad. No: 1 Kat: 3, Bahariye, Kadikoy Istanbul, Turkey Ph sataguler@me.com

23 UPDATE IN THE MANAGEMENT OF MELANOMA 3-4 October Bucharest, Romania Chair: A. Testori, IT Host Chairs: R. Cosgarea, RO - O. Simionescu, RO Seminar Coordinator: S. Gandini, IT The discovery of BRAF, NRAS and KIT mutations and the efficacy of ipilimumab and PD-1 therapies in melanoma led to various rational therapeutic approaches. Promising treatment results highlighted a new paradigm in melanoma treatment based on molecular analysis translated into personalized therapeutic approaches and increasing clinical benefit. The ESO Seminar will provide participants with an unbiased update on this innovations but will also review all the other aspects of melanoma management from diagnostic to palliative care. Learning objectives: A 2-day residential educational event Full immersion Clinically-oriented Multidisciplinary, to cover pathology, staging and diagnostics, biology, immunology technologies with an overview on medical and surgical oncology Participant s profile: Age between 25 and 50 years Dermatologists, surgical oncologists, medical oncologists, pathologists, immunologists, research nurses Involvement in scientific activities Fluency in English Main topics: Molecular diagnostics and biology Update on personalized therapeutic approaches Roberta Ventura, rventura@eso.net, ph ESO Education n 23

24 ESO-esso MASTERCLASS IN BREAST CANCER SURGERY 4-7 October Ermatingen (Lake Constance), Switzerland Chairs: A. Costa, IT - M. Leidenius, FI - L. Wyld, GB Scientific Coordinator: W. Gatzemeier, IT Imperia of Constance The ESO-ESSO Masterclass is a 4-day residential, clinically oriented educational event designed for breast surgeons and surgical oncologists dealing with breast cancer. Participants will be exposed to a full spectrum of issues in the field - in particular at the cutting edge of current concepts of surgical treatment. The programme includes state-of-the-art lectures, meet the expert - type workshops and case presentations and discussions aiming at facilitating the interaction between participants and teachers. The focus of the Masterclass is on evidence-based clinical practice and technical aspects of breast cancer surgery, within a multidisciplinary approach and practice-oriented training. All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Learning objectives: Improve knowledge and skills in the management, treatment, and care in the field Multidisciplinary approach Improve to treat breast cancer as a whole challenge Gain more security to intercourse with special situations and problems Enable participants to implement evidence-based concepts and guidelines of surgical treatment of breast cancer Participant s profile: Age between 30 and 45 years At least 2-3 years experience in surgical oncology / breast cancer surgery Involvement in scientific activities Fluency in English Main topics: Multidisciplinary management of DCIS Skin and Nipple sparing mastectomy Excisional margins - do they really count? RT and breast reconstruction Prophylactic (contralateral) mastectomy Management of axillary nodes (Z0011/ SLNB before /after neoadjuvant chemotherapy/ AMAROS and beyond) DEADLINE BY APPLICATION ONLY: 1 july 2014 Ana Galán European Society of Surgical Oncology (ESSO) Avenue E. Mounier Brussels Belgium ana.galan@essoweb.org and 24 n ESO Education

25 Stop Cancer Now!: Treat the Treatable In collaboration with: October 2014 l Lugano, Switzerland Media partner: WOF 2014 Scientific Committee: F. Cavalli (Chair) A.M.M. Eggermont, L. Norton, P.G. Pelicci, C.P. Wild A third World Oncology Forum - Stop Cancer Now!: Prevent the Preventable will be held in 2015 in Milan, Italy

26 2 ND BREAST CANCER IN YOUNG WOMEN CONFERENCE 6-7 November Tel Aviv, Israel Chairs: F. Cardoso, PT - O. Pagani, CH - A. Partridge, US Host-Chair: B. Kaufman, IL Conference Coordinator: S. Paluch-Shimon, IL Breast cancer in young women is a devastating and complex disease. Breast cancer in women under 40 strikes when these women are at the peak of their reproductive years, family life and careers and still have many years ahead of them to suffer the long-term effects of treatment or the consequences of recurrent disease. The etiology of breast cancer in this population is poorly understood and most clinical trials focus on women who are over the age of 40, thus little evidence-based data is available about the optimal management of these patients. Further research is much needed in this field. This conference is an opportunity for the latest updates on this field and a platform for generating future research concepts and collaborations. It will also include a consensus session that will form the basis for a consensus guidelines manuscript to be published after the Conference. Learning objectives: In depth learning of various aspects of breast cancer in young women Importance of multi-disciplinary management Management of difficult clinical cases Main topics: Hereditary breast cancer Diagnostic tools in young women Local therapy Systemic therapy Pregnancy and breast cancer Fertility preservation Psychosocial aspects Management of side effects Case discussions Oncology nursing (in co-operation with EONS) Participant s profile: Medical oncologists Surgeons Gynaecologists Radiation oncologists Onco-geneticists Phatologists Oncology nurses Patient advocates 26 n ESO Education DEADLINES ABSTRACTS SUBMISSION: 30 JUNE 2014 EARLY REGISTRATION: BY 3 AUGUST 2014 LATE REGISTRATION: BY 12 OCTOBER 2014 ON-SITE REGISTRATION: AFTER 12 OCTOBER 2014 In collaboration with Israel Cancer Association Francesca Marangoni, fmarangoni@eso.net, ph Roberta Ventura, rventura@eso.net, ph

27 3 rd ESO-estro MASTERCLASS IN RADIATION ONCOLOGY 8-12 November Cascais, Portugal Chairs: M. Baumann, DE - J. Bernier, CH - R. Orecchia, IT - R. Pötter, AT ESO and ESTRO are pleased to announce the third edition of the Masterclass in Radiation Oncology, this year with a renewed format offering a deeper look into the state of art and evidence based innovation strategies in radiation oncology. The programme, focusing on the pillars and on the hot topics in radiation oncology, has been designed to offer a unique learning experience and to provide a practice-oriented training to radiotherapists and to clinical oncologists with knowledge in the field. The programme will offer plenary lectures focusing on the state-of-theart treatments and opportunities to integrate emerging technologies and basic research results in innovative clinical strategies. Furthermore, participants will present an innovation or research proposal outlining novel developmental work (physics, imaging, biology, QA, etc.) with a clinically relevant question and study design (first in man, early phase or later phase) that considers the multidisciplinary environment. All participants will reside at the course venue and their participation is compulsory throughout the course, with its approximately 30 hours of programme. The Masterclass will be entirely in English and fluency in English is compulsory for admission. Learning objectives: Evaluation and application of appropriate methodology in translational research, research design, and in the establishment of endpoints Discuss and update on technology research and options, including treatment planning, emerging technologies and trials Improve knowledge on emerging biology research and future perspectives, including systemic treatment, combined treatment, pathology and biological endpoints Understand the importance and benefits of the multidisciplinary approach Participant s profile: Age between 30 and 45 years Knowledge and at least 3 years experience in clinical radiation oncology or medical Oncologists with basic knowledge in radiotherapy Involvement in scientific activities Fluency in English Main topics: Evidence based methodology for innovation in radiation oncology Physics and technology Radio- and cancer biology Clinical radiation oncology Multidisciplinarity DEADLINE BY APPLICATION ONLY: 30 july 2014 Gabriella Axelsson ESTRO European Society for Radiotherapy and Oncology Rue Martin V, Brussels - Belgium Tel Fax : GAxelsson@estro.org ESO Education n 27